Physician profile
Undral Orgil
NPI 1700228392
$3,662.67
in general payments reported to CMS, 2019-2025
24 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.78 · 2020: $147 · 2021: $126 · 2022: $89.91 · 2023: $861 · 2024: $1,304 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,042 · Travel and Lodging: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,041.73 |
| Travel and Lodging | $245.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,202.33 | 2024-2025 | |
| Treace Medical Concepts, INC. | $450.72 | 2023-2025 | |
| Biowound Solutions, INC. | $333.88 | 2025 | Bio-Connekt |
| Integra Lifesciences Corporation | $315.18 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $294.89 | 2021-2024 | |
| Kerecis Limited | $182.03 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $174.26 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $120.20 | 2020-2021 | |
| Reprise Biomedical, INC. | $64.29 | 2023-2024 | Miro3d |
| Smith+Nephew, INC. | $60.31 | 2022-2023 | Renasys Go V2 Home |
| Tactile Systems Technology INC | $56.67 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Davol INC. | $52.02 | 2025 | Surgiphor |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Nevro Corp. | $45.97 | 2023-2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $37.79 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $35.09 | 2024-2025 | Activ.A.C. |
| Ethicon US, LLC | $31.77 | 2024 | Stratafix |
| Djo, LLC | $27.74 | 2019-2021 | |
| Access Pro Medical, LLC | $24.78 | 2023 | Matriderm |
| Depuy Synthes Sales INC. | $22.95 | 2021 | |
| Polynovo North America LLC | $21.87 | 2024 | Novosorb Btm |
| Grt US Holding, INC. | $20.18 | 2021 | |
| Acera Surgical, INC. | $19.15 | 2025 | Restrata Wound Matrix |
| Acell, INC. | $17.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Undral Orgil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.